CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 38 enrolled
Drug / intervention
Melatonin 10 MG Oral Tablet +2 moredrug
Likely dose
Melatonin 10 MG Oral Tabletfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04034771
NCT04034771Phase 3Completed

The Effect of Melatonin Administration on Sedation Level as Adjuvant to Propofol in Mechanically Ventilated Traumatic Brain Injury Patient: RCT

Cairo University·interventional·Posted Jul 26, 2019·Updated Jul 26, 2019

In Brief

A Phase 3 clinical trial evaluating Melatonin 10 MG Oral Tablet, Propofol, and 1 other intervention for TBI (Traumatic Brain Injury). Completed, enrolled 38 participants across 1 site.

Detailed Summary

This study assess the effect of administration of exogenous melatonin as adjuvant to propofol on the level of sedation and consequently the rate of propofol infusion.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesEgypt
Collaborators--

Timeline

Phase 3CompletedFinished
201820192020202120222023202420252026
First PostedJul 26, 2019
Enrollment StartJan 1, 2018
Primary CompletionApr 1, 2018
Study CompletionApr 5, 2018
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 6.9 years ago

Interventions

Melatonin 10 MG Oral Tabletdrug

Melatonin tablets

Propofoldrug

propofol amp

Placebo oral tabletdrug

sugar pill manufactured to mimic melatonin tablets